SKWD vs. ACT, BWIN, FG, OSCR, HGTY, GSHD, NMIH, CS, SPNT, and PLMR
Should you be buying Skyward Specialty Insurance Group stock or one of its competitors? The main competitors of Skyward Specialty Insurance Group include Enact (ACT), The Baldwin Insurance Group (BWIN), F&G Annuities & Life (FG), Oscar Health (OSCR), Hagerty (HGTY), Goosehead Insurance (GSHD), NMI (NMIH), Credit Suisse Group (CS), SiriusPoint (SPNT), and Palomar (PLMR). These companies are all part of the "insurance" industry.
Enact (NASDAQ:ACT) and Skyward Specialty Insurance Group (NASDAQ:SKWD) are both finance companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, risk, profitability, valuation, earnings, community ranking and dividends.
In the previous week, Enact and Enact both had 7 articles in the media. Skyward Specialty Insurance Group's average media sentiment score of 0.97 beat Enact's score of 0.07 indicating that Skyward Specialty Insurance Group is being referred to more favorably in the news media.
Enact has a beta of 0.59, suggesting that its stock price is 41% less volatile than the S&P 500. Comparatively, Skyward Specialty Insurance Group has a beta of 0.6, suggesting that its stock price is 40% less volatile than the S&P 500.
18.0% of Enact shares are held by institutional investors. Comparatively, 94.8% of Skyward Specialty Insurance Group shares are held by institutional investors. 0.2% of Enact shares are held by insiders. Comparatively, 8.0% of Skyward Specialty Insurance Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Enact has higher revenue and earnings than Skyward Specialty Insurance Group. Enact is trading at a lower price-to-earnings ratio than Skyward Specialty Insurance Group, indicating that it is currently the more affordable of the two stocks.
Enact currently has a consensus price target of $0.00, suggesting a potential upside of 0.00%. Skyward Specialty Insurance Group has a consensus price target of $43.78, suggesting a potential upside of 12.60%. Given Skyward Specialty Insurance Group's stronger consensus rating and higher probable upside, analysts plainly believe Skyward Specialty Insurance Group is more favorable than Enact.
Enact received 32 more outperform votes than Skyward Specialty Insurance Group when rated by MarketBeat users. However, 65.96% of users gave Skyward Specialty Insurance Group an outperform vote while only 48.84% of users gave Enact an outperform vote.
Enact has a net margin of 56.19% compared to Skyward Specialty Insurance Group's net margin of 11.52%. Skyward Specialty Insurance Group's return on equity of 17.36% beat Enact's return on equity.
Summary
Skyward Specialty Insurance Group beats Enact on 11 of the 18 factors compared between the two stocks.
Get Skyward Specialty Insurance Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for SKWD and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SKWD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skyward Specialty Insurance Group Competitors List
Related Companies and Tools
Free SKWD Stock Alerts